PRINCIPLE IMP Distribution Statistics
Welcome to our web page showcasing the distribution of treatments across the UK in PRINCIPLE, the national priority treatment trial for COVID-19 in the community. Here, we provide valuable insights into the geographic spread and impact of our trial, highlighting the areas where participants have received innovative treatments. As the largest trial of its kind in the UK, PRINCIPLE aims to evaluate the effectiveness of various treatments for COVID-19 and make a significant contribution to combating the pandemic. Explore the interactive map and data visualizations to see how our trial is reaching communities nationwide and contributing to the advancement of COVID-19 treatments.
To the right is a map featuring all 7 treatments arm and usual care. The PRINCIPLE team distributed these medication directly to the homes of participants in all 4 nations of the UK.
The key for each treatment arm is as follows:
Azithromycin - Light Blue
Budesonide - Marron
Colchicine - Yellow
Doxycycline - Dark Green
Favipiravir - Orange
Hydroxychlorquine - Purple
Ivermectin - Navy
Usual Care - Pink
The graph above illustrates the distribution of treatment packs across different arms throughout the PRINCIPLE trial. As an adaptive platform trial, PRINCIPLE employs a dynamic approach where treatment arms are added or removed based on emerging data and promising new treatments. This innovative trial design enables the efficient testing of multiple treatments for the same conditions without the need to initiate separate trials each time. The graph showcases the quantity of packs distributed over the course of the trial, providing valuable insights into the evolving landscape of treatment options. Explore the graph to visualize the impact and progression of treatment arms throughout the PRINCIPLE study.